United States · FDA National Drug Code directory
doxepin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44183-106_db184464-82a3-4710-a6aa-6a1c437a7bfc
- Product NDC
- 44183-106
- Form
- TABLET
- Composition / generic term
- doxepin hydrochloride
- Labeler
- Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20100801
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (44183-106-30) · 44183-106-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →